Pay in 4 interest-free payments of $6.36 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
The SELECT study showed in November 2023 that semaglutide delivers a 20 percent reduction in major obesity-related adverse cardiovascular events, such as heart attacks or strokes
As a cross-sectional study, we used data from patients during their hospitalization to analyze the status for a short period after the use of the target medication, and there was no information on the long-term follow-up of outpatients and inpatients, which could have some confounding factors
The primary endpoint of the trial was the change in HbA1c levels, a crucial marker for blood sugar control
It happens with any form of rapid weight losswhether from bariatric surgery, severe calorie restriction, or illness
Because of its rapid onset of action (30 sec) and brief duration of action (~5 minutes), it is not recommended for maintenance therapy in myasthenia gravis (Drachman, 2012)
The Nature Communications study was funded in part by the National Institutes of Health (grants P30 AI036214, R01DK121619 and UM1TR004528) and the James B
US$ 29.18
US$ 22.28
US$ 26.73
